---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-008852"
form_type: "8-K"
ticker: "LPCN"
cik: "0001535955"
company_name: "Lipocine Inc."
filed_at: "2026-03-04T23:59:59+00:00"
generated_at: "2026-05-15T21:40:46.171527+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lipocine files $50M ATM equity facility with A.G.P./Alliance Global Partners

## Summary
- Filed prospectus supplement on Feb 26, 2026 for sale of up to $50M common stock via ATM.
- Sales agreement originally dated April 26, 2024 with A.G.P./Alliance Global Partners.
- Legal opinion on share validity from Dorsey & Whitney LLP included as Exhibit 5.1.
- No specific use of proceeds disclosed in the 8-K.

## SEC filing metadata
- accession: 0001493152-26-008852
- form_type: 8-K
- ticker: LPCN
- cik: 0001535955
- company_name: Lipocine Inc.
- filed_at: 2026-03-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1535955/000149315226008852/0001493152-26-008852-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1535955/000149315226008852/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-008852
- JSON: https://secwatch.observer/filing/0001493152-26-008852.json
- Plain text: https://secwatch.observer/filing/0001493152-26-008852.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.